UNSPSC 51283306: Levofuraltadone hydrochloride

This classification denotes an antimicrobial solution C13H16N4O6.ClH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier ZIA9BC2JJR, chemically known as furaltadone hydrochloride, l-, but more generally known as levofuraltadone hydrochloride, which bears US NIH Compound Identifier 56840909. Most nations schedule levofuraltadone hydrochloride under HS 29349990 and SITC 51579. As of Q4 2014, LEVOFURALTADONE HYDROCHLORIDE remains the US FDA Preferred Term for this commodity. SMILES: C1CC(OC1/C=N/N2C[C@@H](OC2=O)CN3CCOCC3)[N+](=O)[O-].CL.

UNSPSC 51283306 Levofuraltadone hydrochloride is a Commodity code for a specific pharmaceutical active ingredient, but the recent state and local opportunities tagged under this code do not reflect procurement of levofuraltadone itself. Instead, the tagged solicitations describe purchases of naloxone (an opioid antagonist) and safe drug deactivation systems, as well as a completed award for doxycycline hyclate and ciprofloxacin hydrochloride tablets through a pharmaceutical warehouse piggyback contract. The mismatch between the code's nominal scope and the actual work being solicited suggests either a tagging error in the source data or that state and local procurement offices are using this code to classify a broader range of pharmaceutical products and related medical supplies. Based on the available records, there is no clear recent activity directly aligned with levofuraltadone hydrochloride procurement.

The two recent opportunities on file include the Illinois Department of Public Health's August 2026 piggyback pharmaceutical warehouse award to Chartwell Rx LLC for doxycycline hyclate and ciprofloxacin hydrochloride tablets through the MMCAP Infuse cooperative purchasing consortium (a completed IFB, not an open solicitation), and Seminole County, Florida's June 2026 IFB for 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries required. The Illinois opportunity involved a $2,999,999.11 total contract value over three years; the Seminole County procurement required E-Verify compliance, drug-free workplace certification, and specific insurance coverage. Activity appears scattered across state health departments and county health agencies in Florida and Illinois, with no clear pattern suggesting sustained market demand under this specific code classification.